KBC Group NV boosted its holdings in shares of Ligand Pharmaceuticals by 49.7% during the 4th quarter. KBC Group NV now owns 904 shares of the biotechnology company’s stock worth $97,000 after ...

Arizona State Retirement System increased its position in shares of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND – Free ...

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Ligand Pharma (LGND – Research Report), GoodRx Holdings (GDRX – Research Report) and Lifestance Health Group ...

In contrast, after adding 20 mg/kg of monoclonal antibody against CD40 ligand to the regimen on days 0 and 2, we observed four thromboembolic complications in nine recipients. These included two ...